Thoracic paravertebral anesthesia for percutaneous radiofrequency ablation of hepatic tumors

Federico Piccioni, Luca Fumagalli, Francesco Garbagnati, Giuseppe Di Tolla, Vincenzo Mazzaferro, Martin Langer

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Study Objective: To present our preliminary experience using a thoracic paravertebral block (TPVB) as the sole anesthetic in percutaneous hepatic radiofrequency ablation (RFA). Design: Retrospective case series of 12 ASA physical status 1, 2, and 3 patients of average risk scheduled for RFA. Setting: University medical center. Measurements: The first 12 procedures performed using TPVB were analyzed to evaluate the efficacy and safety of this anesthetic technique. Data collected included patients' characteristics, procedure, pain referred during paravertebral punctures, and RFA (verbal numerical scale; VNS). Anesthesia and medical records also were reviewed for any major complications that occurred during or after the RFA. Main Results: Ten of the 12 patients presented for hepatocellular carcinoma; the other two patients had melanoma metastasis. Nine patients were ASA physical status 1 or 2; the other three patients were ASA physical status 3. Nine had liver cirrhosis. All patients had normal coagulation profiles. The TPVBs were performed in a median time of 6.5 (4-15) minutes. Onset of sensory loss to pinprick test occurred approximately 15 to 20 minutes after the injections. No evidence of bilateral blockade was seen in any patient. In most cases, the extent of anesthesia ranged from T6 to T11 or T12. In one patient (no. 2), the stimulating needle elicited no sensory or motor response at the T7 level; the local anesthetic was then injected one cm beyond the transverse process. All patients were very pleased with their anesthetic care; all were discharged from the hospital with no procedure-related complications. Conclusion: The use of thoracic paravertebral block as the sole anesthetic for RFA of liver produced satisfactory unilateral anesthesia and minor adverse events.

Original languageEnglish
Pages (from-to)271-275
Number of pages5
JournalJournal of Clinical Anesthesia
Volume26
Issue number4
DOIs
Publication statusPublished - 2014

Fingerprint

Thorax
Anesthesia
Liver
Neoplasms
Anesthetics
Referred Pain
Local Anesthetics
Punctures
Liver Cirrhosis
Needles
Medical Records
Hepatocellular Carcinoma
Melanoma
Neoplasm Metastasis
Safety
Injections

Keywords

  • Liver neoplasms
  • Nerve block
  • Pulsed radiofrequency treatment
  • Radiofrequency ablation
  • Regional anesthesia
  • Thoracic paravertebral block

ASJC Scopus subject areas

  • Anesthesiology and Pain Medicine
  • Medicine(all)

Cite this

Thoracic paravertebral anesthesia for percutaneous radiofrequency ablation of hepatic tumors. / Piccioni, Federico; Fumagalli, Luca; Garbagnati, Francesco; Di Tolla, Giuseppe; Mazzaferro, Vincenzo; Langer, Martin.

In: Journal of Clinical Anesthesia, Vol. 26, No. 4, 2014, p. 271-275.

Research output: Contribution to journalArticle

Piccioni, Federico ; Fumagalli, Luca ; Garbagnati, Francesco ; Di Tolla, Giuseppe ; Mazzaferro, Vincenzo ; Langer, Martin. / Thoracic paravertebral anesthesia for percutaneous radiofrequency ablation of hepatic tumors. In: Journal of Clinical Anesthesia. 2014 ; Vol. 26, No. 4. pp. 271-275.
@article{4e134e1ce9764531873fc0245069bbb4,
title = "Thoracic paravertebral anesthesia for percutaneous radiofrequency ablation of hepatic tumors",
abstract = "Study Objective: To present our preliminary experience using a thoracic paravertebral block (TPVB) as the sole anesthetic in percutaneous hepatic radiofrequency ablation (RFA). Design: Retrospective case series of 12 ASA physical status 1, 2, and 3 patients of average risk scheduled for RFA. Setting: University medical center. Measurements: The first 12 procedures performed using TPVB were analyzed to evaluate the efficacy and safety of this anesthetic technique. Data collected included patients' characteristics, procedure, pain referred during paravertebral punctures, and RFA (verbal numerical scale; VNS). Anesthesia and medical records also were reviewed for any major complications that occurred during or after the RFA. Main Results: Ten of the 12 patients presented for hepatocellular carcinoma; the other two patients had melanoma metastasis. Nine patients were ASA physical status 1 or 2; the other three patients were ASA physical status 3. Nine had liver cirrhosis. All patients had normal coagulation profiles. The TPVBs were performed in a median time of 6.5 (4-15) minutes. Onset of sensory loss to pinprick test occurred approximately 15 to 20 minutes after the injections. No evidence of bilateral blockade was seen in any patient. In most cases, the extent of anesthesia ranged from T6 to T11 or T12. In one patient (no. 2), the stimulating needle elicited no sensory or motor response at the T7 level; the local anesthetic was then injected one cm beyond the transverse process. All patients were very pleased with their anesthetic care; all were discharged from the hospital with no procedure-related complications. Conclusion: The use of thoracic paravertebral block as the sole anesthetic for RFA of liver produced satisfactory unilateral anesthesia and minor adverse events.",
keywords = "Liver neoplasms, Nerve block, Pulsed radiofrequency treatment, Radiofrequency ablation, Regional anesthesia, Thoracic paravertebral block",
author = "Federico Piccioni and Luca Fumagalli and Francesco Garbagnati and {Di Tolla}, Giuseppe and Vincenzo Mazzaferro and Martin Langer",
year = "2014",
doi = "10.1016/j.jclinane.2013.11.019",
language = "English",
volume = "26",
pages = "271--275",
journal = "Journal of Clinical Anesthesia",
issn = "0952-8180",
publisher = "Elsevier Inc.",
number = "4",

}

TY - JOUR

T1 - Thoracic paravertebral anesthesia for percutaneous radiofrequency ablation of hepatic tumors

AU - Piccioni, Federico

AU - Fumagalli, Luca

AU - Garbagnati, Francesco

AU - Di Tolla, Giuseppe

AU - Mazzaferro, Vincenzo

AU - Langer, Martin

PY - 2014

Y1 - 2014

N2 - Study Objective: To present our preliminary experience using a thoracic paravertebral block (TPVB) as the sole anesthetic in percutaneous hepatic radiofrequency ablation (RFA). Design: Retrospective case series of 12 ASA physical status 1, 2, and 3 patients of average risk scheduled for RFA. Setting: University medical center. Measurements: The first 12 procedures performed using TPVB were analyzed to evaluate the efficacy and safety of this anesthetic technique. Data collected included patients' characteristics, procedure, pain referred during paravertebral punctures, and RFA (verbal numerical scale; VNS). Anesthesia and medical records also were reviewed for any major complications that occurred during or after the RFA. Main Results: Ten of the 12 patients presented for hepatocellular carcinoma; the other two patients had melanoma metastasis. Nine patients were ASA physical status 1 or 2; the other three patients were ASA physical status 3. Nine had liver cirrhosis. All patients had normal coagulation profiles. The TPVBs were performed in a median time of 6.5 (4-15) minutes. Onset of sensory loss to pinprick test occurred approximately 15 to 20 minutes after the injections. No evidence of bilateral blockade was seen in any patient. In most cases, the extent of anesthesia ranged from T6 to T11 or T12. In one patient (no. 2), the stimulating needle elicited no sensory or motor response at the T7 level; the local anesthetic was then injected one cm beyond the transverse process. All patients were very pleased with their anesthetic care; all were discharged from the hospital with no procedure-related complications. Conclusion: The use of thoracic paravertebral block as the sole anesthetic for RFA of liver produced satisfactory unilateral anesthesia and minor adverse events.

AB - Study Objective: To present our preliminary experience using a thoracic paravertebral block (TPVB) as the sole anesthetic in percutaneous hepatic radiofrequency ablation (RFA). Design: Retrospective case series of 12 ASA physical status 1, 2, and 3 patients of average risk scheduled for RFA. Setting: University medical center. Measurements: The first 12 procedures performed using TPVB were analyzed to evaluate the efficacy and safety of this anesthetic technique. Data collected included patients' characteristics, procedure, pain referred during paravertebral punctures, and RFA (verbal numerical scale; VNS). Anesthesia and medical records also were reviewed for any major complications that occurred during or after the RFA. Main Results: Ten of the 12 patients presented for hepatocellular carcinoma; the other two patients had melanoma metastasis. Nine patients were ASA physical status 1 or 2; the other three patients were ASA physical status 3. Nine had liver cirrhosis. All patients had normal coagulation profiles. The TPVBs were performed in a median time of 6.5 (4-15) minutes. Onset of sensory loss to pinprick test occurred approximately 15 to 20 minutes after the injections. No evidence of bilateral blockade was seen in any patient. In most cases, the extent of anesthesia ranged from T6 to T11 or T12. In one patient (no. 2), the stimulating needle elicited no sensory or motor response at the T7 level; the local anesthetic was then injected one cm beyond the transverse process. All patients were very pleased with their anesthetic care; all were discharged from the hospital with no procedure-related complications. Conclusion: The use of thoracic paravertebral block as the sole anesthetic for RFA of liver produced satisfactory unilateral anesthesia and minor adverse events.

KW - Liver neoplasms

KW - Nerve block

KW - Pulsed radiofrequency treatment

KW - Radiofrequency ablation

KW - Regional anesthesia

KW - Thoracic paravertebral block

UR - http://www.scopus.com/inward/record.url?scp=84904256892&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84904256892&partnerID=8YFLogxK

U2 - 10.1016/j.jclinane.2013.11.019

DO - 10.1016/j.jclinane.2013.11.019

M3 - Article

VL - 26

SP - 271

EP - 275

JO - Journal of Clinical Anesthesia

JF - Journal of Clinical Anesthesia

SN - 0952-8180

IS - 4

ER -